Christopher P. Lapointe

1.1k total citations
22 papers, 663 citations indexed

About

Christopher P. Lapointe is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Infectious Diseases. According to data from OpenAlex, Christopher P. Lapointe has authored 22 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 3 papers in Cardiology and Cardiovascular Medicine and 2 papers in Infectious Diseases. Recurrent topics in Christopher P. Lapointe's work include RNA and protein synthesis mechanisms (18 papers), RNA Research and Splicing (14 papers) and RNA modifications and cancer (13 papers). Christopher P. Lapointe is often cited by papers focused on RNA and protein synthesis mechanisms (18 papers), RNA Research and Splicing (14 papers) and RNA modifications and cancer (13 papers). Christopher P. Lapointe collaborates with scholars based in United States, Switzerland and South Africa. Christopher P. Lapointe's co-authors include Marvin Wickens, Joseph D. Puglisi, Jinfan Wang, Alex G. Johnson, Rosslyn Grosely, Daniel Wilinski, I.S. Fernandez, Junhong Choi, Arjun Prabhakar and Zachary T. Campbell and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Christopher P. Lapointe

20 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher P. Lapointe United States 14 551 101 54 42 40 22 663
Agustina P. Bertolin Argentina 11 279 0.5× 116 1.1× 29 0.5× 24 0.6× 35 0.9× 15 409
Theodora Myrto Perdikari United States 6 376 0.7× 88 0.9× 32 0.6× 44 1.0× 27 0.7× 10 468
Varandt Y. Khodaverdian United States 4 443 0.8× 77 0.8× 14 0.3× 21 0.5× 94 2.4× 8 526
Ranen Aviner Israel 11 376 0.7× 28 0.3× 26 0.5× 30 0.7× 71 1.8× 13 480
Jacqueline Franke Germany 12 474 0.9× 54 0.5× 19 0.4× 76 1.8× 31 0.8× 13 586
Huan Jin United States 8 232 0.4× 121 1.2× 24 0.4× 50 1.2× 15 0.4× 16 451
Naushaba Hasin United States 8 370 0.7× 53 0.5× 18 0.3× 168 4.0× 40 1.0× 11 446
Edward J. Miracco United States 9 482 0.9× 61 0.6× 25 0.5× 67 1.6× 7 0.2× 10 594
Alan M.V. West United States 4 237 0.4× 156 1.5× 15 0.3× 23 0.5× 61 1.5× 5 374
Boris J.A. Dyakov Canada 6 378 0.7× 51 0.5× 14 0.3× 31 0.7× 63 1.6× 7 481

Countries citing papers authored by Christopher P. Lapointe

Since Specialization
Citations

This map shows the geographic impact of Christopher P. Lapointe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Lapointe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Lapointe more than expected).

Fields of papers citing papers by Christopher P. Lapointe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher P. Lapointe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Lapointe. The network helps show where Christopher P. Lapointe may publish in the future.

Co-authorship network of co-authors of Christopher P. Lapointe

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher P. Lapointe. A scholar is included among the top collaborators of Christopher P. Lapointe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher P. Lapointe. Christopher P. Lapointe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Addetia, Amin, Daniel Asarnow, Young‐Jun Park, et al.. (2025). SARS-CoV-2 nsp1 mediates broad inhibition of translation in mammals. Cell Reports. 44(5). 115696–115696.
2.
Grosely, Rosslyn, Carlos Alvarado, Ivaylo P. Ivanov, et al.. (2025). eIF1 and eIF5 dynamically control translation start site fidelity. Nature Structural & Molecular Biology. 32(11). 2308–2318. 3 indexed citations
3.
Palo, Michael Z., Betty Ha, Christopher P. Lapointe, et al.. (2025). Conserved long-range interactions are required for stable folding of orthoflaviviral genomic RNA. Nucleic Acids Research. 53(11).
4.
Schubert, Katharina, Evangelos D. Karousis, Christopher P. Lapointe, et al.. (2023). Universal features of Nsp1-mediated translational shutdown by coronaviruses. Molecular Cell. 83(19). 3546–3557.e8. 24 indexed citations
5.
Hentschel, Jendrik, Junhong Choi, Clive R. Bagshaw, et al.. (2023). Real-time detection of human telomerase DNA synthesis by multiplexed single-molecule FRET. Biophysical Journal. 122(17). 3447–3457. 1 indexed citations
6.
Lapointe, Christopher P., Rosslyn Grosely, Masaaki Sokabe, et al.. (2022). eIF5B and eIF1A reorient initiator tRNA to allow ribosomal subunit joining. Nature. 607(7917). 185–190. 38 indexed citations
7.
Lapointe, Christopher P., Rosslyn Grosely, Alex G. Johnson, et al.. (2021). Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation. Proceedings of the National Academy of Sciences. 118(6). 119 indexed citations
8.
Johnson, Alex G., Ryan A. Flynn, Christopher P. Lapointe, et al.. (2020). A memory of eS25 loss drives resistance phenotypes. Nucleic Acids Research. 48(13). 7279–7297. 9 indexed citations
9.
Johnson, Alex G., Christopher P. Lapointe, Jinfan Wang, et al.. (2019). RACK1 on and off the ribosome. RNA. 25(7). 881–895. 39 indexed citations
10.
Wickens, Marvin, Melanie A. Preston, Douglas F. Porter, et al.. (2019). TRAID-seq: Unbiased analysis of RNA tailing enzyme activity at single-nucleotide resolution. Protocol Exchange. 1 indexed citations
11.
Wang, Jinfan, Alex G. Johnson, Christopher P. Lapointe, et al.. (2019). eIF5B gates the transition from translation initiation to elongation. Nature. 573(7775). 605–608. 52 indexed citations
12.
Preston, Melanie A., Douglas F. Porter, Christopher P. Lapointe, et al.. (2019). Unbiased screen of RNA tailing activities reveals a poly(UG) polymerase. Nature Methods. 16(5). 437–445. 46 indexed citations
13.
Lapointe, Christopher P. & Joseph D. Puglisi. (2018). Ribosomal Protein Dynamics on the Human Ribosome. Biophysical Journal. 114(3). 595a–595a. 1 indexed citations
14.
Choi, Junhong, Rosslyn Grosely, Arjun Prabhakar, et al.. (2018). How Messenger RNA and Nascent Chain Sequences Regulate Translation Elongation. Annual Review of Biochemistry. 87(1). 421–449. 52 indexed citations
15.
Lapointe, Christopher P., et al.. (2017). Architecture and dynamics of overlapped RNA regulatory networks. RNA. 23(11). 1636–1647. 27 indexed citations
16.
Lapointe, Christopher P., Jonathan A. Stefely, Adam Jochem, et al.. (2017). Multi-omics Reveal Specific Targets of the RNA-Binding Protein Puf3p and Its Orchestration of Mitochondrial Biogenesis. Cell Systems. 6(1). 125–135.e6. 69 indexed citations
17.
Lapointe, Christopher P. & Marvin Wickens. (2017). RNA Tagging: Preparation of High-Throughput Sequencing Libraries. Methods in molecular biology. 1649. 455–471. 2 indexed citations
18.
Lapointe, Christopher P., et al.. (2015). Protein-RNA networks revealed through covalent RNA marks. Nature Methods. 12(12). 1163–1170. 71 indexed citations
19.
Wilinski, Daniel, Chen Qiu, Christopher P. Lapointe, et al.. (2015). RNA regulatory networks diversified through curvature of the PUF protein scaffold. Nature Communications. 6(1). 8213–8213. 47 indexed citations
20.
Lapointe, Christopher P. & Marvin Wickens. (2013). The Nucleic Acid-binding Domain and Translational Repression Activity of a Xenopus Terminal Uridylyl Transferase. Journal of Biological Chemistry. 288(28). 20723–20733. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026